Piramal Pharma informs about disclosure

23 May 2024 Evaluate

With reference to its letter dated 24th February, 2024 regarding US FDA Inspection at Piramal Pharma’s manufacturing facility located at Lexington, USA. In furtherance to the aforementioned intimation, Piramal Pharma has informed that US FDA has issued an Establishment Inspection Report (EIR) for the said manufacturing facility and the inspection has now been successfully closed by the US FDA. 

The above information is a part of company’s filings submitted to BSE.

Piramal Pharma Share Price

156.60 1.40 (0.90%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×